Proteins left behind by COVID-19 long after initial infection can cause cortisol levels in the brain to plummet, inflame the nervous system and prime its immune cells to hyper-react when another stressor arises, according to new animal research by CU Boulder scientists.
The study, published in the journal , sheds new light on what might underlie the neurological symptoms of long COVID, an intractable syndrome that impacts as many as 35% of those infected with the virus.
The findings come as COVID makes a striking late summer comeback, with .
“Our study suggests that low cortisol could be playing a key role in driving many of these physiological changes that people are experiencing with long COVID,” said lead author Matthew Frank,Ěýa senior research associate with the Department of Psychology and Neuroscience at CU Boulder.
Previous research has shown that SARS-CoV-2 antigens, immune-stimulating proteins shed by the virus that causes COVID-19, linger in the blood of long COVID patients as much as a year after infection. They’ve also been detected in the brains of COVID patients who have died.
Role of COVID spike protein subunit
To explore just how such antigens impact the brain and nervous system, the research team injected an antigen called S1 (a subunit of the “spike” protein) into the spinal fluid of rats and compared them to a control group.
After seven days, levels of the cortisol-like hormone corticosterone plummeted by 31% in the hippocampus of rats exposed to S1. That is the region of the brain associated with memory, decision making and learning. After nine days, levels were down 37%.
“Nine days is a long time in the life span of a rat,” said Frank, noting that rats live on average for two to three years.
Matt Frank
He noted that cortisol is a critical anti-inflammatory agent, helps convert fuel into energy and is important for regulating blood pressure and the sleep-wake cycle and keeping the immune response to infection in check. One recent study showed that people with long COVID tend to have low cortisol levels—as do people with chronic fatigue syndrome, research shows.
“Cortisol has so many beneficial properties that, if it is reduced, it can have a host of negative consequences,” said Frank.
In another experiment, the researchers exposed different groups of rats to an immune stressor (a weakened bacteria) and observed their heart rate, temperature and behavior as well as the activity of glial—or immune—cells in the brain.
They found that the group of rats that had previously been exposed to the COVID protein S1 responded far more strongly to the stressor, with more pronounced changes in eating, drinking, behavior, core body temperature and heart rate, more neuroinflammation and stronger activation of glial cells.
“We show for the first time that exposure to antigens left behind by this virus can actually change the immune response in the brain so that it overreacts to subsequent stressors or infection,” said Frank.
Continuing long COVID research
He stressed that the study was in animals and that more research is necessary to determine whether and how low cortisol might lead to long COVID symptoms in people.
He theorizes that the process might go something like this: COVID antigens lower cortisol, which serves to keep inflammatory responses to stressors in check in the brain. Once a stressor arises—whether it be a bad day at work, a mild infection or a hard workout—the brain’s inflammatory response is unleashed without those limits and serious symptoms come screaming back.
Those might include fatigue, depression, brain fog, insomnia and memory problems.
Frank said he is doubtful that cortisol treatments alone could be an effective treatment for long COVID, as they would not get at the root cause and come with a host of side effects.
Instead, the findings suggest that identifying and minimizing different stressors might help manage symptoms.
Rooting out the source of antigens—including tissue reservoirs where bits of virus continue to hide out—might also be an approach worth exploring.
The study was funded by the nonprofit PolyBio Research Foundation.
“There are many individuals out there suffering from this debilitating syndrome. This research gets us closer to understanding what, neurobiologically, is going on and how cortisol may be playing a role,” said Frank.
